Detalhe da pesquisa
1.
Intensive Safety Monitoring of Rituximab (Biosimilar Novex® and the Innovator) in Pediatric Patients With Complex Diseases.
Front Pharmacol
; 12: 785770, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35153748